Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-24

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating racecadotril for efficacy and safety in infants with acute diarrhea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Racecadotril (racecadotril)

Snippet

Sponsor: Abbott | Conditions: Diarrhea, Infantile | Phase 3 | Status: COMPLETED | Results posted: 2023-11-24